Target intelligence / Profile preview

Phagocytosis promotion

01

Overview

Phagocytosis is a cellular process in which specialized phagocytic cells (e.g., macrophages, neutrophils, dendritic cells, retinal pigment epithelial cells) ingest large extracellular particles (such as microbes, apoptotic bodies, or tissue debris) into phagosomes, which subsequently fuse with lysosomes to degrade the contents. This process is finely regulated by a diverse array of cell-surface receptors, including Fc gamma receptors (FcγRs) that bind antibodies, complement receptors that recognize opsonized targets, pattern-recognition receptors (PRRs), scavenger receptors, and other non-opsonic receptors. Actin cytoskeleton remodeling drives particle engulfment, forming membrane protrusions (pseudopods) that envelop the target and complete internalization. Multiple signals—“eat-me” and “don't-eat-me”—help discriminate targets and modulate phagocytosis, with defective clearance leading to disease states such as cancer, autoimmunity, and neurodegeneration. Phagocytosis can be “promoted” clinically or experimentally by targeting receptors, signaling pathways, or membrane properties affecting phagocytic efficiency, but promotion itself is not a defined molecule or receptor.

02

Biological functions

Immune responseCell debris clearancePathogen removalApoptosis (efferocytosis)Inflammation regulation
03

Disease associations

Cancer (failed clearance can contribute to tumorigenesis)Autoimmune disease (defective efferocytosis causes self-antigen persistence)Infection (defective phagocytosis leads to poor pathogen elimination)Neurodegenerative disease (debris accumulation)Cardiovascular disease (atherosclerosis linked to defective clearance)

Beyond the preview

Go deeper on Phagocytosis promotion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phagocytosis promotion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call